The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner

Journal of Virology

Volumn 76, Issue 1, 2002, Pages 105-117

  Demirov, D G ^a   Orenstein, J M ^a   Freed, E O ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; PROTEIN P6; PROTEIN PRECURSOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL TYPE; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC CONSERVATION; HETEROKARYON; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN MOTIF; STOP CODON; T LYMPHOCYTE; VIRION; VIRUS PARTICLE; VIRUS REPLICATION;

AMINO ACID SEQUENCE; CELLS, CULTURED; CODON, TERMINATOR; EUKARYOTIC CELLS; GENE PRODUCTS, GAG; HELA CELLS; HIV-1; HUMANS; JURKAT CELLS; LYMPHOCYTES; MACROPHAGES; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; VIRUS REPLICATION;

EID: 0036133283     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.1.105-117.2002     Document Type: Article

References (68)

1. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain
2. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone
3. The WW domain: A signalling site in dystrophin?
4. Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras
5. SH3 domains and drug design: Ligands, structure, and biological function
6. gag exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins
7. A syncytia assay for human immunodeficiency virus type I (HIV-I) envelope protein and its use in studying HIV-I mutations
8. HIV-Gag proteins: Diverse functions in the virus life cycle
9. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection
10. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions
11. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gpl20
12. HIV-1 infection of non-dividing cells
13. HIVs and their replication
14. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix
15. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production
16. Identification of retroviral late domains as determinants of particle size
17. Particle size determinants in the human immunodeficiency virus type 1 Gag protein
18. WW domains and retrovirus budding
19. gag protein on human immunodeficiency virus particle release
20. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: Implications for filovirus budding
21. A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: Implications for viral budding
22. Comparative morphology of Gag protein structures produced by mutants of the gag gene of human immunodeficiency virus type 1
23. Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: An ultrastructural study
24. gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease
25. Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release
26. Synthesis of functional human immunodeficiency virus tat protein in baculovirus as determined by a cell-cell fusion assay
27. Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation
28. Role of matrix in an early postentry step in the human immunodeficiency virus type I life cycle
29. Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for Gag budding from cells
30. gag domain of human immunodeficiency virus type 1 is sutficient for the incorporation of Vpr into heterologous viral particles
31. Rapid and efficient site-specific mutagenesis without phenotypic selection
32. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions
33. Mapping of functional domains for HIV-2 gag assembly into virus-like particles
34. SH3 domains: Minding your p's and q's
35. The gag gene products of human immunodeficiency virus type 1: Alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative Gag precursors
36. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and α-helix 2 of the gp41 cytoplasmic tail
37. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions
38. Interaction of tyrosine-based sorting signals with clathrin-associated proteins
39. Characterization of human immunodeficiency virus type 1 matrix revertants: Effects on virus assembly. Gag processing, and Env incorporation into virions
40. Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1- treated human monocytes: An ultrastructural study
41. Ubiquitination of HIV-1 and MuLV Gag
42. gag protein of Moloney murine leukemia virus
43. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins
44. Ubiquitin is part of the retrovirus budding machinery
45. SH2 and SH3 domains: From structure to function
46. Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of Gag and mutational analysis
47. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein
48. Equine infectious anemia virus Gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly
49. Functional domains of HIV-1 gag-polyprotein expressed in baculovirus-infected cells
50. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2
51. Distinct ligand preferences of Src homology 3 domains from Src. Yes. Abl, Cortactin, p53bp2, PLCγ, Crk, and Grb2
52. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly
53. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines
54. A role for ubiquitin ligase recruitment in retrovirus release
55. The ubiquitin-proteasome system and endocytosis
56. Synthesis, assembly, and processing of viral proteins
57. + cell line susceptible to infection by HIV-1
58. Signal-dependent membrane protein trafficking in the endocytic pathway
59. gag
60. Ubiquitin in retrovirus assembly: Actor or bystander?
61. An assembly domain of the Rous sarcoma virus Gag protein required late in budding
62. gag late assembly domain
63. A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release
64. Generation of high-titer pseudotyped retroviral vectors with very broad host range
65. gag domain result in reduced retention of Pol proteins during virus assembly
66. Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation
67. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses
68. Gag protein affect virion production and early events of the virus life cycle